[1-(β-Mercapto-β, β-Cyclopentamethylenepropionic Acid), 2-(O-Methyl)Tyrosine]Arginine-Vasopressin and [1-(β-Mercapto-β, β-Cyclopentamethylenepropionic Acid)]Arginine-Vasopressin, Two Highly Potent Antagonists of the Vasopresso

Journal of Medicinal Chemistry

Volumn 23, Issue 4, 1980, Pages 364-368

  Kruszynski, Marian ^a   Lammek, Bernard ^a   Manning, Maurice ^a   Seto, Janny ^b   Haidar, Jaya ^b   Sawyer, Wilbur H ^b  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b College of Physicians and Surgeons of Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; ARGIPRESSIN[1 (3,3 CYCLOPENTAMETHYLENE 3 MERCAPTOPROPIONIC ACID) 2 (O METHYLTYROSINE)]; ARGIPRESSIN[1 (3,3 CYCLOPENTAMETHYLENE 3 MERCAPTOPROPIONIC ACID)]; OXYTOCIN; UNCLASSIFIED DRUG; VASOPRESSIN ANTAGONIST; VASOPRESSIN DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; DIURESIS; DRUG ANTAGONISM; DRUG COMPARISON; DRUG SYNTHESIS; FEMALE GENITAL SYSTEM; PRELIMINARY COMMUNICATION; PRESSOR RESPONSE; RAT; UTERUS CONTRACTILITY;

ANIMALS; ARGININE VASOPRESSIN; BLOOD PRESSURE; DIURESIS; FEMALE; MAGNESIUM; RATS; STRUCTURE-ACTIVITY RELATIONSHIP; UTERINE CONTRACTION;

EID: 0018897308     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00178a003     Document Type: Article

References (33)

1. M. Manning, J. Lowbridge, C. T. Stier, Jr., J. Haidar, and W. H. Sawyer, J. Med. Chem. 20, 1228 (1977).
2. J. Lowbridge, M. Manning, J. Haidar, and W. H. Sawyer, J. Med. Chem. 21, 313 (1978).
3. M. Manning, L. Balaspiri, M. Acosta, and W. H. Sawyer, J. Med. Chem. 16, 975 (1973).
4. D. B. Hope, V. V. S. Murti, and V. du Vigneaud, J. Biol. Chem. 237, 1563 (1962).
5. H. Schulz and V. du Vigneaud, J. Med. Chem. 9, 647 (1966).
6. J. J. Nestor, Jr., M. F. Ferger, and V. du Vigneaud, J. Med. Chem. 18, 284 (1975).
7. D. F. Dyckes, J. J. Nestor, Jr., M. F. Ferger, and V. du Vigneaud, J. Med. Chem. 17, 250 (1974);.
8. D. F. Dyckes, J. J. Nestor, Jr., M. F. Ferger, V. du Vigneaud, and W. Y. Chan, J. Med. Chem. 17, 969 (1974).
9. H. O. Schild, Br. J. Phrmacol. 2, 189 (1947).
10. J. J. Crofton, L. Share, R. E. Shade, M. Manning, and W. H. Sawyer, Hypertension 1, 31 (1979).
11. C. C. Y. Pang, J. R. McNeill, W. C. Wilcox, M. Manning, and W. H. Sawyer, Proc. Soc. Exp. Biol. Med. 161, 41 (1979);.
12. A. W. Cowley, Jr., S. J. Switzer, and M. M. Guinn, Circ. Res. 46, 58 (1980).
13. H. B. Law and V. du Vigneaud, J. Am. Chem. Soc. 82, 4579 (1960).
14. R. L. Huguenin and R. A. Boissonnas, Helv. Chim. Acta 49, 695 (1966);.
15. M. Manning, L. Balaspiri, J. Moehring, J. Haidar, and W. H. Sawyer, J. Med. Chem. 19, 842 (1976).
16. K. Bankowski, M. Manning, J. Haidar, and W. H. Sawyer, J. Med. Chem. 21, 850 (1978).
17. R. B. Merrifield, J. Am. Chem. Soc. 85, 2149 (1963).
18. R. B. Merrifield, Biochemistry 3, 1385 (1964).
19. M. Manning, J. Am. Chem. Soc. 90, 1348 (1968).
20. M. Manning, J. Lowbridge, J. Haidar, and W. H. Sawyer, J. Med. Chem. 19, 376 (1976).
21. J. Lowbridge, M. Manning, J. Haidar, and W. H. Sawyer, J. Med. Chem. 20, 1173 (1977).
22. M. Bodanszky and V. du Vigneaud, J. Am. Chem. Soc. 81, 5688 (1959).
23. M. Bodanszky, M. Kondo, C. Y. Lin, and G. F. Sigler, J. Org. Chem. 39, 444 (1974).
24. W. Konig and R. Geiger, Chem. Ber. 103, 788 (1970).
25. V. du Vigneaud, C. Ressler, J. M. Swan, P. Katsoyannis, and C. W. Roberts, J. Am. Chem. Soc. 76, 3115 (1954).
26. M. Manning, T. C. Wuu, and J. W. M. Baxter, J. Chromatogr. 38, 396 (1968).
27. J. Lowbridge, M. Manning, J. Seto, J. Haidar, and W. H. Sawyer, J. Med. Chem. 22, 565 (1979).
28. W. H. Sawyer, J. Haidar, D. Gazis, J. Seto, K. Bankowski, J. Lowbridge, A. Turan, and M. Manning, Endocrinology 106, 81 (1980).
29. B. F. Gisin, Helv. Chim. Acta 56, 1476 (1973).
30. D. H. Spackman, W. H. Stein, and S. Moore, Anal. Chem. 30, 1190 (1958).
31. S. Moore, J. Biol. Chem. 238, 235 (1963).
32. J. Dekanski, Br. J. Pharmacol. 7, 567 (1952).
33. W. H. Sawyer, M. Acosta, L. Balaspiri, J. Judd, and M. Manning, Endocrinology. 94, 1106 (1974).